NCT04251949 2026-03-18
MuciLight
Centre Oscar Lambret
Phase 2 Completed
Clinical Trials
52 trialsNCT05388058 2026-01-16
Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
Phase 2 Completed
NCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
NCT06186700 2025-07-28
Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer
Mansoura University
Phase 2 Completed
NCT05133076 2025-06-26
OIC1
BioGaia Pharma AB
Phase 2 Completed
NCT04752384 2025-04-20
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
Medical College of Wisconsin
Phase 2 Completed
NCT06538272 2025-04-03
Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel
Ono Pharmaceutical Co. Ltd
Phase 2 Completed
NCT04499950 2025-03-06
A-NEW
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT03233776 2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2 Completed
NCT04099901 2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2 Completed
NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
NCT04046250 2023-08-25
TK112690
Tosk, Inc.
Phase 2 Completed
NCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02932332 2023-04-21
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01434290 2022-06-09
Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT04730375 2022-05-05
Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients
National Cancer Institute, Egypt
Phase 2 Completed
NCT03101514 2021-06-23
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Phase 2 Completed
NCT01003483 2021-04-01
Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
Yazd Research & Clinical Center for Infertility
Phase 2 Completed
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03152591 2021-01-05
PCOS
Novartis
Phase 2 Completed
NCT04635852 2020-11-19
EFFENDYS
University of Cologne
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01317940 2020-07-08
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Children's Hospital Los Angeles
Phase 2 Completed
NCT02152462 2020-02-10
POWER
Georgetown University
Phase 2 Completed
NCT01880528 2020-01-02
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
Mayo Clinic
Phase 2 Completed
NCT02058849 2019-08-14
Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
University of Kentucky
Phase 2 Completed
NCT00179517 2019-07-17
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT02123511 2019-04-30
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT02270983 2019-04-08
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Forest Laboratories
Phase 2 Completed
NCT01312467 2019-03-05
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
National Cancer Institute (NCI)
Phase 2 Completed
NCT02324335 2019-01-16
Brilacidin
Innovation Pharmaceuticals, Inc.
Phase 2 Completed
NCT02885376 2018-12-21
Study of Dentoxol® Mouthrinse for Oral Mucositis
Ingalfarma SpA
Phase 2 Completed
NCT00513656 2018-10-23
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Mundipharma Research GmbH & Co KG
Phase 2 Completed
NCT01898091 2017-03-06
OM
Medical University of South Carolina
Phase 2 Completed
NCT01484873 2017-03-03
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Vanderbilt University Medical Center
Phase 2 Completed
NCT00095927 2017-01-04
Randomized Amifostine For SCCHN
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02252926 2016-08-16
Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Hvidovre University Hospital
Phase 2 Completed
NCT02063295 2016-07-18
An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
Zafgen, Inc.
Phase 2 Completed
NCT00003323 2016-07-04
Hormone Therapy in Treating Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00934128 2016-03-02
High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01004393 2016-02-02
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Phase 2 Completed
NCT01004094 2016-01-20
SQ!II
Baylor College of Medicine
Phase 2 Completed
NCT00135577 2015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT00698204 2014-06-05
Cox-2 Inhibition in Radiation-induced Oral Mucositis
UConn Health
Phase 2 Completed
NCT00698035 2014-06-02
E-String
University of California, San Francisco
Phase 2 Completed
NCT00984334 2013-12-27
Naloxone SR Capsules in Patients With Opioid Induced Constipation
S.L.A. Pharma AG
Phase 2 Completed
NCT00561314 2013-08-26
High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01375088 2012-11-22
Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers
Mashhad University of Medical Sciences
Phase 2 Completed
NCT00004895 2012-06-06
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Northwestern University
Phase 2 Completed